炎症体
细胞内
溶血
细胞生物学
补体系统
细胞骨架
细胞溶解
补体膜攻击复合物
阵发性夜间血红蛋白尿
化学
卡尔帕因
程序性细胞死亡
蛋白质水解
炎症
细胞
CD59型
过敏毒素
半胱氨酸蛋白酶1
红细胞
蛋白酶
溶解
半胱氨酸蛋白酶
免疫学
穿孔
细胞膜
信号转导
经典补体途径
NLRP1
上睑下垂
作者
Nikhil Ranjan,Michael Cole,Gloria Gerber,Daniel Flores-Guerrero,Shruti Chaturvedi,Robert Brodsky
标识
DOI:10.64898/2026.07.20.26358486
摘要
Abstract Paroxysmal Nocturnal Hemoglobinuria (PNH) is characterized by hemolysis due to the loss of GPI-anchored complement regulators. While terminal complement inhibitors improve survival, the precise intracellular mechanisms driving the destruction of PNH erythrocytes remain controversial. A recently proposed model suggests PNH cells undergo an inflammatory programmed cell death (“spectosis”) driven by an NLRP3-Caspase-8 signaling cascade. Here, we use a whole packed cell lysis approach to map the cytoskeletal degradation of primary erythrocytes across a 22-patient PNH cohort. Our data show that membrane attack complex (MAC) pore formation drives targeted β-spectrin fragmentation, which correlates with rapid intracellular potassium (K + ) efflux. Notably, when probing these primary patient samples, we detected a complete absence of the NLRP3 protein and found no functional evidence of Caspase-8 activation during MAC pore formation. Furthermore, caspase inhibition did not alter cytoskeletal degradation or K + efflux. Instead, our data demonstrate that MAC-induced membrane perforation permits a rapid influx of calcium, which activates calpain, the dominant calcium-dependent protease in erythrocytes. Rather than an inflammatory cascade, this calcium-dependent calpain activity executes the degradation of β-spectrin. These findings challenge current models of PNH hemolysis. We show that the destruction of PNH erythrocytes is a consequence of the MAC-calcium-calpain axis, rather than an inflammatory programmed cell death event. Consequently, therapeutic strategies aimed at targeting the inflammasome or caspase signaling will likely offer no clinical benefit for PNH patients. Graphical abstract
科研通智能强力驱动
Strongly Powered by AbleSci AI